The November release really caught my attention "Ms. Helms works with private equity firms, medical start-up companies and medical device inventors who are seeking licensees and/or strategic partners. Prior to Morgan Wallace Associates, Meg spent 31 years with Johnson & Johnson ("J&"J). During this time, she was responsible for new business development, closing dozens of M&A transactions and contributing to a cumulative Business Unit revenue growth of over $500 million. She is particularly skilled at handling complex global acquisitions, most recently in Israel and China.
the BOD continues to focus on sourcing long-term financing for closing potential bolt-on acquisitions and closing several joint venture deals in 2017 that will expand operational capacities and stimulate sales of the Company's Global ECG Management Software (GEMS™ WIN), handheld HeartCheck™ ECG devices and SMART Monitoring ECG services."